TetraLogic Pharmaceuticals Corporation

TLOGOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$979

P/E Ratio—

52W High$0.001

52W Low$0.00004

Avg Volume178

Open$0.00

Beta4.06

Overview

TetraLogic Pharmaceuticals Corporation（TLOG）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · TLOG · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

中性

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

TetraLogic Pharmaceuticals Corporation内部人在过去近12个月买卖活动混合。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

近期内幕交易记录

TLOG 高管卖出股份 · TLOG 董事内幕交易 · SEC Form 4申报

显示最近 55 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Feb 8, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	103,123	$0.19	$20K	2,445,030	Form 4
Feb 9, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	230,507	$0.16	$37K	2,214,523	Form 4
Feb 3, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	82,583	$0.15	$12K	3,881,060	Form 4
Feb 4, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	500,026	$0.14	$70K	3,381,034	Form 4
Feb 5, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	832,881	$0.20	$167K	2,548,153	Form 4
Jan 29, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	52,826	$0.26	$14K	4,279,949	Form 4
Feb 1, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	140,000	$0.20	$28K	4,139,949	Form 4
Feb 2, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	176,306	$0.17	$30K	3,963,643	Form 4
Jan 26, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	69,425	$0.30	$21K	4,575,280	Form 4
Jan 27, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	209,984	$0.27	$57K	4,365,296	Form 4
Jan 28, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	32,521	$0.26	$8K	4,332,775	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	9,200	$2.79	$26K	184,830	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	800	$2.75	$2K	175,630	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	7,608	$2.75	$21K	174,830	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	6,900	$2.74	$19K	167,222	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	10,000	$2.74	$27K	160,322	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	2,100	$2.69	$6K	150,322	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	908	$2.66	$2K	148,222	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	1,092	$2.65	$3K	147,314	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	92	$2.57	$236	146,222	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	1,300	$2.54	$3K	146,130	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	10,000	$2.44	$24K	144,830	Form 4
Jul 9, 2015	Pecora Andrew L Director	Purchase	10,000	$2.41	$24K	134,830	Form 4
Jul 9, 2015	Pecora Andrew L Director	Purchase	40,000	$2.40	$96K	124,830	Form 4
Mar 27, 2015	Meyers Pete A. CFO & Treasurer	Purchase	5,000	$4.35	$22K	153,891	Form 4

Clarus Lifesciences II, L.P.

10 percent owner

Sale

日期

Feb 8

股数

103,123

均价

$0.19

总金额

$20K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

日期

Feb 9

股数

230,507

均价

$0.16

总金额

$37K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

日期

Feb 3

股数

82,583

均价

$0.15

总金额

$12K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

日期

Feb 4

股数

500,026

均价

$0.14

总金额

$70K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

日期

Feb 5

股数

832,881

均价

$0.20

总金额

$167K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

日期

Jan 29

股数

52,826

均价

$0.26

总金额

$14K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

日期

Feb 1

股数

140,000

均价

$0.20

总金额

$28K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

日期

Feb 2

股数

176,306

均价

$0.17

总金额

$30K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

日期

Jan 26

股数

69,425

均价

$0.30

总金额

$21K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

日期

Jan 27

股数

209,984

均价

$0.27

总金额

$57K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

日期

Jan 28

股数

32,521

均价

$0.26

总金额

$8K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 10

股数

9,200

均价

$2.79

总金额

$26K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 10

股数

800

均价

$2.75

总金额

$2K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 10

股数

7,608

均价

$2.75

总金额

$21K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 10

股数

6,900

均价

$2.74

总金额

$19K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 10

股数

10,000

均价

$2.74

总金额

$27K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 10

股数

2,100

均价

$2.69

总金额

$6K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 10

股数

908

均价

$2.66

总金额

$2K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 10

股数

1,092

均价

$2.65

总金额

$3K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 10

股数

均价

$2.57

总金额

$236

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 10

股数

1,300

均价

$2.54

总金额

$3K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 10

股数

10,000

均价

$2.44

总金额

$24K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 9

股数

10,000

均价

$2.41

总金额

$24K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

日期

Jul 9

股数

40,000

均价

$2.40

总金额

$96K

View Form 4 on SEC.gov

Meyers Pete A.

CFO & Treasurer

Purchase

日期

Mar 27

股数

5,000

均价

$4.35

总金额

$22K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 3

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 TLOG 内幕交易

TLOG 内幕交易

TetraLogic Pharmaceuticals Corporation（TLOG）内幕交易数据来源于公司内部人（包括TLOG）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。TLOG内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看TetraLogic Pharmaceuticals Corporation机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

TLOG 内幕交易 · 5个问题

TetraLogic Pharmaceuticals Corporation（TLOG）的内部人包括高管和董事，如TLOG等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

TLOG 董事内幕交易TLOG 内部人名单TetraLogic Pharmaceuticals Corporation 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026